Literature DB >> 18397933

Rescue peri-operative management of the patient with giant electrical storm and severe left ventricular dysfunction: support by levosimendan and intraaortic balloon counterpulsation.

Tomas Vanek1, Miroslav Kolesar, Michal Nejedly, Radovan Jirmar.   

Abstract

We present a case of a 62-year-old male patient (coronary heart disease, and stenosis of aortic valve) with severe left ventricular dysfunction (left ventricular ejection fraction 20%, left ventricular end-diastolic diameter 80 mm, end-diastolic volume 329 ml) who developed giant electrical storm (on the whole 115 episodes of pulseless ventricular tachycardia treated by antiarrhythmics and electrical discharges) with low-elevation of cardiac biomarkers. The patient was referred to emergent cardiac surgery (double coronary bypass grafting, aortic valve replacement, and implantation of left ventricular epicardial electrode). Levosimendan and intraaortic balloon counterpulsation were used for successful weaning from the cardiopulmonary bypass; no other arrhythmia appeared in the post-bypass period. Postoperatively no arrhythmic events were detected, and repeated echocardiographic examinations of the patient in good general condition showed gradual improvement of left ventricular ejection fraction (30-35%), likewise in other parameters (left ventricular end-diastolic diameter 72 mm, end-diastolic volume 285 ml).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18397933     DOI: 10.1510/icvts.2008.176883

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  2 in total

1.  Effective cardiopulmonary resuscitation - how long is not long enough?

Authors:  Ranju Singh; Neha Baduni; Deepak Bansal; Homay Vajifdar
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-01

2.  Predictive value of CHADS2 and CHA2DS2-VASc scores for coronary artery lesions and in-hospital prognosis of patients with acute ST-segment elevation myocardial infarction.

Authors:  Xiaoli Li; Zhen Zeng; Xinchun Yang; Hongjiang Wang
Journal:  BMC Cardiovasc Disord       Date:  2021-09-15       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.